| Summary of Operating segments |
For the year ended December 31, 2025 | | Marketing and Distribution of Commercial Products | | | Retail and Mail Order Pharmacy | | | Total | | Revenue | | $ | 8,569 | | | $ | 20,286 | | | $ | 28,855 | | Cost of goods sold | | | (4,325 | ) | | | (12,782 | ) | | | (17,107 | ) | Operating expenses | | | (12,375 | ) | | | (6,261 | ) | | | (18,636 | ) | Finance income (expense), net | | | (63 | ) | | | 185 | | | | 122 | | Foreign exchange loss | | | (123 | ) | | | - | | | | (123 | ) | Income (loss) before income taxes | | $ | (8,317 | ) | | $ | 1,428 | | | $ | (6,889 | ) |
For the year ended December 31, 2024 | | Marketing and Distribution of Commercial Products | | | Retail and Mail Order Pharmacy | | | Total | | Revenue | | $ | 11,076 | | | $ | 10,831 | | | $ | 21,907 | | Cost of goods sold | | | (3,886 | ) | | | (4,932 | ) | | | (8,818 | ) | Operating expenses | | | (12,325 | ) | | | (3,501 | ) | | | (15,826 | ) | Other income | | | 1,860 | | | | - | | | | 1,860 | | Finance income (expense), net | | | (19 | ) | | | 184 | | | | 165 | | Foreign exchange loss | | | (71 | ) | | | - | | | | (71 | ) | Income (loss) before income taxes | | $ | (3,365 | ) | | $ | 2,582 | | | $ | (783 | ) |
|